Cite

    Hanada, K. et al. (2015). Personalized immunotherapy for non-small cell lung cancer through identification of tumor-specific mutations by next generation sequencing and adoptive transfer of tumor infiltrating lymphocytes that recognize neoantigens. Journal for immunotherapy of cancer. 3 (2), pp. 1-2. [Online].